⌘K

Login Start Free

Home/Filings/4/0001327111-25-000007

4//SEC Filing

Seely Lynn 4

Accession 0001327111-25-000007

CIK 0001806952other

View on SEC.gov Company Profile

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 8:36 PM ET

Size

4.7 KB

Accession

0001327111-25-000007

Insider Transaction Report

Form 4

Period: 2025-11-10

Lyell Immunopharma, Inc.LYEL

DirectorPresident and CEO

Transactions

Sale
Common Stock
2025-11-10$16.11/sh−412$6,637→ 67,159 total

Footnotes (1)

[F1]Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

Documents

1 file

4
form4-11132025_011139.xmlPrimary

Issuer

Lyell Immunopharma, Inc.

CIK 0001806952

Entity typeother

Related Parties

1

filerCIK 0001327111

Filing Metadata

Form type: 4
Filed: Nov 11, 7:00 PM ET
Accepted: Nov 12, 8:36 PM ET
Size: 4.7 KB

View on SEC.gov